Compare WPRT & ZYXI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | WPRT | ZYXI |
|---|---|---|
| Founded | 1995 | 1996 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 30.7M | 35.8M |
| IPO Year | 1995 | N/A |
| Metric | WPRT | ZYXI |
|---|---|---|
| Price | $1.70 | $0.76 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 2 | 3 |
| Target Price | ★ $4.50 | $3.00 |
| AVG Volume (30 Days) | 80.3K | ★ 14.6M |
| Earning Date | 11-10-2025 | 11-17-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $290,323,000.00 | $108,202,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $9.30 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 140.81 | N/A |
| 52 Week Low | $1.54 | $0.38 |
| 52 Week High | $4.78 | $8.72 |
| Indicator | WPRT | ZYXI |
|---|---|---|
| Relative Strength Index (RSI) | 42.30 | 42.36 |
| Support Level | $1.59 | $0.75 |
| Resistance Level | $1.86 | $0.95 |
| Average True Range (ATR) | 0.08 | 0.29 |
| MACD | 0.01 | -0.01 |
| Stochastic Oscillator | 41.94 | 7.48 |
Westport Fuel Systems Inc is an organization engaged in the engineering, manufacturing, and supply of alternative fuel systems and components for transportation applications. It has three operating segments; the Original Equipment Manufacturers segment-design, manufacture, and sell alternative fuel systems, components and electronics, and related engineering services, to OEMs that serve light-duty, medium-duty, and heavy-duty customers, the Independent Aftermarket segment includes IAM products, conversion kits, and components allow for the conversion of vehicles after being sold to the end-user through a network of dealers and installers, and Corporate includes public company activities, corporate oversight, financing and capital allocation.
Zynex Inc is engaged in the manufacturing and marketing of medical devices. It operates through one primary business segment, Electrotherapy and Pain Management Products. The business activities of the company are carried out through its subsidiaries. The company designs, manufactures, and markets medical devices that treat chronic and acute pain, as well as activate and exercise muscles for rehabilitative purposes with electrical stimulation. The company operates business as one operating segment which includes two revenue types: Devices and Supplies. Its markets Zynex-manufactured products which include NexWave, NeuroMove, InWave E-Wave, and others.